Top brokers name 3 ASX small cap shares to buy

Immutep Ltd (ASX:IMM) and these small cap ASX shares have been named as buys by brokers. Here's why they are bullish on them…

| More on:
Businessman with hands on hips looks at share price chart with the words 'buy' and 'sell '

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

As well as covering large caps like Afterpay Ltd (ASX: APT) and Telstra Corporation Ltd (ASX: TLS), many brokers also cover smaller companies.

In light of this, I thought I would scour through a range of recent notes to see which small cap ASX shares are in favour with brokers at present.

Three that have been given buy ratings are listed below. Here's why brokers like them:

Immutep Ltd (ASX: IMM)

According to a note out of Bell Potter, its analysts have a speculative buy rating and 85 cents price target on this biotechnology company's shares. The broker notes that Immutep has recently been granted Fast Track status by the US FDA for its efti product candidate. This relates to a trial for first line recurrent or metastatic head and neck squamous cell carcinoma (HNSCC). The broker has increased the probability of success for the treatment in response to this and envisages licensing deals in 2023 if all goes to plan. The Immutep share price is fetching 44.5 cents this afternoon.

Silk Laser Australia Ltd (ASX: SLA)

Analysts at Ord Minnett currently have a buy rating and $5.06 price target on this laser, skin care, and cosmetic injections company's shares. According to the note, the broker was very happy with Silk Laser's performance during the first half. It notes that demand was so strong that the company upgraded its earnings guidance. Positively, Ord Minnett appears confident that Silk can easily achieve the top end of its new guidance range. The Silk Laser share price is trading at $4.50 on Friday.

Telix Pharmaceuticals Ltd (ASX: TLX)

A note out of Wilsons reveals that its analysts have an overweight rating and $5.40 price target on this clinical-stage biopharmaceutical company's shares. According to the note, the broker was pleased to see Novartis report positive results from a trial of Lu-PSMA-617 for prostate cancer. It believes this development is a big positive for Telix, which has a similar therapy – TLX591-CDx. Its ProstACT trial starts soon and will test TLX591 as a second line therapy. The Telix share price is fetching $3.94 on Friday afternoon.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Telstra Limited. The Motley Fool Australia owns shares of AFTERPAY T FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

Broker looking at the share price.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

A man in a blue collared shirt sits at his desk doing a single fist pump as he watches the Appen share price rise on his laptop
Broker Notes

These ASX 200 stocks could rise 30% to 40%

Analysts are tipping these shares to go to the moon. Let's find out why.

Read more »

A businessman looking at his digital tablet or strategy planning in hotel conference lobby. He is happy at achieving financial goals.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Man pointing at a blue rising share price graph.
Technology Shares

Up 30% in a month, this ASX 200 tech share is 'a compelling opportunity': expert

Analysts from listed investment company WAM Capital say this ASX 200 tech stock is worth watching.

Read more »

An executive in a suit smooths his hair and laughs as he looks at his laptop feeling surprised and delighted.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

View of a mine site.
Broker Notes

How much upside does Macquarie tip for Deterra Royalties shares?

Deterra Royalties offers ASX investors a different way to invest in global mining.

Read more »

Woman with $50 notes in her hand thinking, symbolising dividends.
Broker Notes

Broker reveals outlook for ASX dividend shares amid volatile market

Peter Gardner from Plato Investment Management tells ASX investors where to look for dividend income this year.

Read more »

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Broker Notes

Leading broker puts buy rating on Zip shares

Big returns could be on offer for investors according to its analysts.

Read more »